| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2009 | CN101427139A Biomarkers for endometrial proliferation |
| 05/06/2009 | CN101426916A Improved interleukin-2 muteins |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426813A Immunomodulatory and anti-tumour peptides |
| 05/06/2009 | CN101426808A Novel protein transduction domains and uses therefor |
| 05/06/2009 | CN101426807A Neuroprotective compounds and uses thereof |
| 05/06/2009 | CN101426530A Wound healing polymer compositions and methods for use thereof |
| 05/06/2009 | CN101426520A Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) |
| 05/06/2009 | CN101426519A Human GLP-1 mimetibodies, compositions, methods and uses |
| 05/06/2009 | CN101426518A Methods and compositions for treating asthma in human and non human primates |
| 05/06/2009 | CN101426517A Pharmaceutical composition containing GHRP-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue |
| 05/06/2009 | CN101426516A Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases |
| 05/06/2009 | CN101426515A Novel enterococcus and streptococcus strains and bacteriocins |
| 05/06/2009 | CN101426514A HCV vaccines |
| 05/06/2009 | CN101426513A Composition containing peptide as active ingredient |
| 05/06/2009 | CN101426512A Methods of treating conditions involving neuronal degeneration |
| 05/06/2009 | CN101426511A Chemically-modified progenipoietin conjugates |
| 05/06/2009 | CN101423555A Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
| 05/06/2009 | CN101423554A Antivariant streptococcus polypeptide and use thereof and preparation method |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423550A Genetic engineering immunosuppressive polypeptide and preparation method and application |
| 05/06/2009 | CN101422614A Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 05/06/2009 | CN101422603A Insoluble biological activity protein as vitreous body oral medicine for treating ophthalmic diseases |
| 05/06/2009 | CN101422602A Function food capable of improving the women cimacteric symptom |
| 05/06/2009 | CN101422601A Preparation method and new use of human middle factor Midkine |
| 05/06/2009 | CN101422600A Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating multiple sclerosis disease |
| 05/06/2009 | CN101422599A Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating rheumatoid arthritis |
| 05/06/2009 | CN101422598A Use of active material containing oxytocin in treating rheumatoid arthritis |
| 05/06/2009 | CN101422485A Preparation method of spleen byproducts for producing homology anti-serum blood and transfer factor from fox, raccoon dog, mink |
| 05/06/2009 | CN101422431A Insulation administration preparation through nose |
| 05/06/2009 | CN100485038C Miniaturized Staphylococcus aureus polypeptide of against drug-resistance and its uses and preparation method |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100484959C Modified recombinant porcine alpha interferon protein and coding gene and uses thereof |
| 05/06/2009 | CN100484957C Thymosin beta4 derivative and its use |
| 05/06/2009 | CN100484954C Method for purifying drug active protein by cation exchange chromatogrphy |
| 05/06/2009 | CN100484575C Chromatin peptide medicinal molecule for sealing MYC cell proliferation path |
| 05/06/2009 | CN100484570C Gene vaccine against SARS virogene and its construction and use |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484568C Antibiosis usage of a family of protein |
| 05/05/2009 | US7528250 1-(7-Benzenesulfonylchroman-4-yl)-piperazine and derivatives; serotonin receptor antagonists; cognition activators; Alzheimer's disease |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528244 Protein for use in the diagnosis and treatment of cell death defects |
| 05/05/2009 | US7528237 Binding to monoclonal antibodies; antitumor agents |
| 05/05/2009 | US7528233 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders |
| 05/05/2009 | US7528232 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in crop plants |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528228 For use as medicinal products, as intermediates for producing peptides and as a spacer arm in pharmaceutical compositions intended to take biologically active principles specifically to certain cells of the body |
| 05/05/2009 | US7528227 Histone H2A peptide derivatives and uses thereof |
| 05/05/2009 | US7528226 TGFβ1-inhibitor peptides |
| 05/05/2009 | US7528225 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
| 05/05/2009 | US7528174 Conjugates of Gramicidin S peptidyl fragments, tetramethylpentamethylene nitroxide and derivatives; hemorrhagic shock, myocardial ischemia, myocardial reperfusion, solid organ transplantation, hemorrhagic shock, septic shock, stroke, tissue damage due to ionizing radiation, lung injury, acute lung injury |
| 05/05/2009 | US7528141 Use of cyclopenta[g]quinazoline derivatives for treating cancer |
| 05/05/2009 | US7528117 High efficacy antisense RIαPKA poly-DNP oligoribonucleotides |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7528113 Method and composition for the treatment of adenoviral ocular infections |
| 05/05/2009 | US7528112 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
| 05/05/2009 | US7528111 Method of vaccinating subjects receiving immune modulating therapy |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7528109 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/05/2009 | US7528108 Administering zinc-charged, protease-digested protein (derived, for example, from serum or milk) and carrier, excipient or diluent; induces apoptosis of an adipocyte; non-invasive weight loss treatment that would act by reducing the number of fat cells |
| 05/05/2009 | US7528107 Alpha -defensins (by neutrophils or Paneth cells) is administered to inhibit the post translational processing and release of interleukin-1 beta |
| 05/05/2009 | US7528106 Angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor; peptide, pegaptanib sodium, EMD 472523; antiangiogenic drugs |
| 05/05/2009 | US7528105 Heterodimeric chain synthetic heparin-binding growth factor analogs |
| 05/05/2009 | US7528104 Peptides that bind to the erythropoietin receptor |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527954 Compartmentalisation of nucleic acids together with an in vitro transcription-translation mixture in a water-in-oil emulsion, the expression of fusion polypeptides coded by the nucleic acids; fusion polypeptides are covalently bonded to the nucleic acid coding for the fusion polypeptide |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527925 Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct |
| 05/05/2009 | US7527802 For therapy against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby |
| 05/05/2009 | US7527797 Capsular polysaccharide of Vibrio cholerae O139 covalently bound with an adipic acid dihydrazide linker to a recombinant diphtheria toxin carrier protein eliciting serum vibriocidal antibodies; conjugated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), |
| 05/05/2009 | US7527795 Peptide epitopes of apolipoprotein B |
| 05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
| 05/05/2009 | US7527793 Immunogenic peptides |
| 05/05/2009 | US7527792 Arg-arg-leu-ser-tyr-ser-arg-arg-arg-phe decapeptide bonded to drug such as doxorubicin via maleimide derivative linkage; preventing chemoresistance or drug resistance; gene expression inhibition of multidrug resistance gene |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | US7527787 Multivalent immunoglobulin-based bioactive assemblies |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | US7527785 Using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited; neurodegenerative diseases, Alzheimer's and Parkinson's disease; antiepileptic agents; drug delivery |
| 05/05/2009 | CA2590540C The use of neurotoxic component of a botulinum toxin for the treatment of excessive mucus secretion |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2309818C Buffered drug formulations for transdermal electrotransport delivery |
| 05/05/2009 | CA2280931C Matrix-free osteogenic devices, implants and methods of use thereof |
| 05/05/2009 | CA2274116C Use, of an inhibitor of thioredoxin, for inhibiting tumor growth |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 05/05/2009 | CA2146647C Treatment of autoimmune and inflammatory disorders |
| 05/01/2009 | CA2606828A1 Methods of assessing and treating pulmonary disease |
| 04/30/2009 | WO2009055779A1 A method for reversal of bacterial resistance to metallo-b-lactamase antibiotics and vancomycin |
| 04/30/2009 | WO2009055675A1 Methods of identifying histone deacetylase inhibitors useful for neurological disorders |
| 04/30/2009 | WO2009055653A1 Pegylation by the dock and lock (dnl) technique |
| 04/30/2009 | WO2009055538A1 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 04/30/2009 | WO2009055421A1 Chimeric c3-like rho antagonist cardiac therapeutic |
| 04/30/2009 | WO2009055351A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| 04/30/2009 | WO2009055350A1 Methods of treating chronic neurogenic inflammation using modified clostridial toxins |
| 04/30/2009 | WO2009055313A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/30/2009 | WO2009055042A1 Enhancing the efficacy of anti-infective therapeutics |